Functional Outcome Of Treatment Of Intertrochanteric Fractures Using Proximal Femoral Nail In Lateral Decubitus Versus Supine Position On Fracture Table
European Journal of Molecular & Clinical Medicine,
2020, Volume 7, Issue 8, Pages 3561-3570
AbstractFractures of the proximal femur are common fractures in elderly persons. Several epidemiological studies have suggested that the incidence of fractures of the proximal femur arises because the general life expectancy of the people has risen during the past few decades. To evaluate the advantages, disadvantages, and complications associated with the treatment of inter-trochanteric fractures with proximal femoral nail (PFN) in supine and lateral decubitus position. Patients with intertrochanteric fractures attending Saveetha medical college and hospital from June 2019to November 2019 were included in the study. Out of the total patients, 40 patients who fulfilled inclusion criteria were taken up for study and grouped into two groups supine and lateral decubitus position groups randomly at a 1:1 ratio. All the patients have been explained about the clinical trial and that by agreeing to participate, the patient has a 50:50 chance of being grouped into two different groups. The informed consent for participation in the study was obtained from all the patients. In the present study out of the 40 patients, 20 patients were treated with Proximal femoral nail in lateral decubitus position (Group A) and 20 patients were treated with the proximal femoral nail in supine position over a fracture table (Group B). All patients were operated under spinal anesthesia or general anesthesia. The operating time needed for proximal femoral nailing in lateral position (mean and standard deviation,91.75± 11.502 minutes) was significantly lower(p=0.000) than that needed for supine position (mean and standard deviation, 111.25±8.251798 minutes). PFN is an effective method for the treatment of inter-trochanteric fractures both in supine and lateral positions.
- Article View: 23
- PDF Download: 5